Patient-oriented Research: Colon CA & Cancer Immunology
Patient-oriented Research: Colon CA & Cancer Immunology
批准号:
7386702
负责人:
RANDALL F HOLCOMBE
金额:
$14.96万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-04-19 至 2011-03-31
关键词:
10qAXIN2 geneAcademiaAcademic Medical CentersActivities of Daily LivingAdjuvantAdultAdverse eventAffectAgarAgar Gel ElectrophoresisAlkaline PhosphataseAmerican Association of Cancer ResearchAmerican Society of Clinical OncologyAmerican Society of HematologyAmino AcidsAnatomyAncillary StudyAnimal ModelAntibodiesAntigen PresentationAntigen Presentation PathwayAntigen-Presenting CellsAntigensAntineoplastic AgentsAntioxidantsAntisense RNAApoptosisApoptoticAppearanceAppendixApplications GrantsAreaArmadillo RepeatAtrial Natriuretic FactorAutomobile DrivingAwardB-LymphocytesBMP4Basement membraneBindingBinding SitesBiochemistryBioflavonoidBiologicalBiological AssayBiological MarkersBiological ModelsBiological SciencesBiometryBionBiopsyBiopsy SpecimenBiotechnologyBloodBlood CirculationBone Marrow SuppressionBostonBrachyury proteinBuffersC-terminalCC chemokine receptor 7CCND1 geneCCND2 geneCCR1 geneCCR5 geneCCR8 geneCD19 geneCD44 geneCD80 geneCMV promoterCOL1A1 geneCSF2 geneCTBP1 geneCTBP2 geneCTNNB1 geneCXCR4 geneCadherinsCalciumCaliforniaCancer BiologyCancer CenterCancer EtiologyCancer Immunology ScienceCancer PatientCancer Therapy Evaluation ProgramCancer cell lineCancerousCapecitabine/OxaliplatinCase Report FormCategoriesCell CountCell Cycle ProteinsCell LineCell LineageCell NucleusCell ProliferationCell Proliferation RegulationCell Surface ReceptorsCell physiologyCell surfaceCellsCellular AssayCellular StructuresCellular biologyCetuximabCharacteristicsChemopreventionClassClassificationClinicClinicalClinical InvestigatorClinical MedicineClinical NutritionClinical OncologyClinical ProtocolsClinical ResearchClinical Research ProtocolsClinical TreatmentClinical TrialsClinical Trials DesignClinical trial protocol documentCoculture TechniquesColonColon CarcinomaColonic NeoplasmsColonic PolypsColonoscopyColorectalColorectal CancerCommitCommon NeoplasmCommunity HealthComplementComplementary DNAComplexComprehensive Cancer CenterConditionConfocal MicroscopyConnexin 43ContractsControlled EnvironmentCorrelative StudyCost Effectiveness AnalysisCouplingCrabsCulture MediaCultured CellsCytolysisCytoplasmCytoskeletonCytotoxic ChemotherapyDNADNA Microarray ChipDNA Microarray formatDailyDataDendritic CellsDepthDescriptive EpidemiologyDetectionDevelopmentDevelopmental Cell BiologyDevicesDiagnosisDietary AssessmentDigoxigeninDimethyl SulfoxideDisciplineDiseaseDissectionDoctor of PhilosophyDocumentationDominant-Negative MutationDoseDown-RegulationDrug resistanceE-CadherinE250EP300 geneEarly DiagnosisEcologyEconomicsEctopic ExpressionEducational CurriculumEffectivenessEligibility DeterminationEmbryoEmbryonic DevelopmentEnd PointEndothelial CellsEnrollmentEnvironmental EpidemiologyEnvironmental HealthEnzymesEpidemiologyEpidermal Growth Factor ReceptorEpithelialEpithelial CellsEpitheliumEtiologyEvaluable DiseaseEvaluationEventExcisionExhibitsExperimental DesignsExposure toExtracellular ProteinExtramural ActivitiesFGF4 geneFOSL1 geneFRAT1 geneFZD2 geneFZD3 geneFZD4 geneFZD6 geneFZD7 geneFZD9 geneFacultyFamilyFamily memberFeedbackFellowshipFellowship ProgramFlow CytometryFluorescenceFluorescence MicroscopyFluorochromeFluorouracilFluorouracil/Irinotecan/Leucovorin CalciumFluorouracil/Leucovorin CalciumFollistatinFormalinFoundationsFreezingFresh TissueFundingFutureGTP-Binding ProteinsGastric GlandsGastric TissueGastrinsGastroenterologyGelatinase AGene ExpressionGene Expression RegulationGene TargetingGenesGeneticGenetic TranscriptionGenus ColaGerm-Line MutationGermanyGlutathione S-TransferaseGoalsGrantGranulocyte-Macrophage Colony-Stimulating FactorGrapesGroup MeetingsGrowthGrowth FactorHST OncogeneHT29 CellsHandHeadHealthHealth Care CostsHealth ServicesHematologyHemeHereditary Nonpolyposis Colorectal NeoplasmsHistologicHomeostasisHourHumanHuman ResourcesHydrolysisICAM1 geneID2 geneIL3RA geneITGAX geneImageryImmuneImmune responseImmune systemImmunizationImmunohistochemistryImmunologicsImmunologyImmunosuppressionIn SituIn Situ HybridizationIn VitroIncubatedIndiumIndividualInflammatoryInflammatory Bowel DiseasesInformed ConsentInheritedInstitutesInstructionIntegrin alpha3Interferon Type IIInterferonsIntervention StudiesIntestinal MucosaInvestigationJUN geneJournalsK-Series Research Career ProgramsLabelLaboratoriesLaboratory ResearchLaboratory ScientistsLaboratory StudyLasersLeadLeadershipLengthLettersLevamisoleLife ExpectancyLigandsLocalized DiseaseLocationLouisianaLuc GeneLungMAPK8 geneMHC Class I GenesMHC Class II GenesMSX1 geneMYB geneMaintenanceMalignant - descriptorMalignant NeoplasmsMalignant neoplasm of lungMalignant neoplasm of nasopharynxMalignant neoplasm of pancreasMalignant neoplasm of prostateManufacturer NameManuscriptsMarketingMatrix MetalloproteinasesMeasurementMeasuresMediatingMedicalMedical OncologyMedical ResearchMedical StudentsMedicineMembraneMentored Clinical Oncology AwardMentored Clinical Scientist AwardMentored Patient-Oriented Research Career Development AwardMentorsMentorshipMessenger RNAMetastatic/RecurrentMethodologyMethodsMicroarray AnalysisMicrobiologyMicrosatellite InstabilityMid-Career Clinical Scientist Award (K24)Midcareer Investigator Award in Patient-Oriented ResearchMinorModelingMolecularMolecular AnalysisMolecular BiologyMolecular GeneticsMolecular ProfilingMonitorMonoclonal AntibodiesMorusMucous MembraneMusMutateMutationNCAM1 geneNOS2A geneNamesNational Institute of Diabetes and Digestive and Kidney DiseasesNational Surgical Adjuvant Breast and Bowel ProjectNatural Killer CellsNeckNeoplasm MetastasisNeutropeniaNorthern BlottingNuclearNucleic Acid Regulatory SequencesNumbersNurse PractitionersNursesNursing FacultyNutritional StudyNylonsOffice of the DirectorOligonucleotide PrimersOligonucleotide ProbesOncologic NursingOncology NurseOperative Surgical ProceduresOrganOrthopedicsOryctolagus cuniculusOutcomeOxidation-ReductionPLAUR genePPP2R5D genePTGS2 genePathogenesisPathologicPathway interactionsPatient CarePatient SchedulesPatientsPatternPeanuts - dietaryPeer ReviewPerceptionPeripheralPeripheral Blood Mononuclear CellPharmaceutical PreparationsPharmacologic SubstancePharmacologyPhasePhase II Clinical TrialsPhenotypePhosphotransferasesPhysiciansPilot ProjectsPlacementPlantsPlasmidsPlayPolymerase Chain ReactionPopulationPopulation GroupPositioning AttributePostdoctoral FellowPre-studyPredispositionPremalignantPreparationPreventionPreventiveProbenecidProceduresProcessProductionProtein Kinase CProtein OverexpressionProtein Phosphatase 2A Regulatory Subunit PR53ProteinsProto-Oncogene Proteins c-junProto-Oncogene Proteins c-mybProtocols documentationPublic HealthPublicationsPublishingPurposeRNARNA ProbesRangeRateReaderReagentReceptor SignalingRecombinant DNARecommendationRecruitment ActivityRectal CancerRecurrenceRefractoryRegulationReporterReportingResearchResearch ActivityResearch DesignResearch Ethics CommitteesResearch PersonnelResearch Project GrantsResearch ProposalsResearch TrainingResourcesRestResveratrolReverse Transcriptase Polymerase Chain ReactionReview CommitteeRiskRoleRotationSFRP4 geneSample SizeSamplingSchoolsScientistScoreSecureSentinelSequence AnalysisSeriesSideSignal PathwaySignal TransductionSignaling MoleculeSignaling Pathway GeneSimplexvirusSiteSkinSlideSmall Interfering RNASocietiesSolutionsSourceSouthwest Oncology GroupSpecificitySpecimenStagingStaining methodStainsStandards of Weights and MeasuresStem cellsStomachStressStudentsStudy SectionSubgroupSulindacSupport of ResearchSurrogate EndpointSurrogate MarkersSystemT-LymphocyteTATA BoxTCF7L2 geneTP53 geneTechniquesTechnologyTestingTherapeuticTherapeutic Clinical TrialTherapeutic EffectTherapeutic TouchTherapeutic immunosuppressionTherapy Clinical TrialsThymidine KinaseTimeTissue SampleTissuesTitleTopoisomerase I inhibitionToxic effectTrainingTraining ProgramsTranscriptional ActivationTransfectionTranslational ResearchTreatment EffectivenessTumor AngiogenesisTumor AntigensTumor Cell InvasionTumor ImmunityTumor TissueTumor-DerivedUnited States Food and Drug AdministrationUnited States National Institutes of HealthUniversitiesUniversity of California Irvine Cancer CenterUp-RegulationVaccinesVariantVascular Endothelial Growth FactorsVenous blood samplingWNT1 geneWNT10A geneWNT11 geneWNT2 geneWNT2B geneWNT3 geneWNT4 geneWNT5A geneWNT5A proteinWNT6 geneWNT7A geneWNT9A geneWagesWeekWestern BlottingWnt proteinsWorkWritingabstractingangiogenesisanticancer researchbacteriophage T3 RNA polymerasebasebeta cateninc-myc GenescDNA Arrayscancer cellcancer diagnosiscancer epidemiologycancer immunology functioncancer preventioncancer research center directorcancer typecapsulecareercelecoxibcell growthcell motilitychemokinechemokine receptorchemotherapychiron vaccinecohortcolon cancer cell linecolon carcinogenesiscolonic cryptconceptcostcyclooxygenase 2cytokinedaydesigndietary supplementsdisorder controldosageepithelial to mesenchymal transitionexperienceextracellularfunctional genomicsgastrointestinalgenetic epidemiologyhuman MMP14 proteinhuman NOS2A proteinhuman PPP2R5D proteinhuman SFRP4 proteinhuman WNT10A proteinhuman WNT11 proteinhuman WNT2 proteinhuman WNT2B proteinhuman WNT3 proteinhuman WNT4 proteinhuman WNT6 proteinhuman WNT7A proteinhuman WNT9A proteinhuman studyimmune functionimmunoregulationimprovedin vivoinhibitor/antagonistinstructorinterestiron metabolismjun Oncogenelaser capture microdissectionlymph nodeslymphoid enhancer-binding factor 1mRNA Expressionmalignant breast neoplasmmalignant stomach neoplasmmatrigelmatrix metalloproteinase 26medical schoolsmembermigrationmolecular oncologymonocytemutantneoplasticneoplastic cellnovelnovel strategiesnovel therapeuticsoncologyosteosarcomaoutcome forecastoxaliplatinpatient orientedpatient oriented researchperipheral bloodprofessorprogenitorprogramspromoterprotein activationprotein expressionproto-oncogene protein kfgfquality assurancereceptorreceptor expressionreconstitutionred winerelease of sequestered calcium ion into cytoplasmrepairedresearch studyresponserhoslugsocialstatisticssuccesssymposiumtraffickingtranscription factortranslational clinical trialtrendtrizoltumortumor growthtumor immunologytumor progressiontumorigenesistype I collagen alpha 1uncontrolled cell growthvectorvector control
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This application is submitted as a competitive renewal of a midcareer investigator award in patient-oriented
research (K24CA82450). The PI is Randall F. Holcombe, MD. This application details the experience,
qualifications and short- and long-term patient-oriented research plans of Dr. Holcombe, as well as reviews
progress during the period of support under the current award. Details about current and planned patient-
oriented research is provided. These studies are focused on patient-oriented research in colon cancer and
include studies related to the Wnt signaling pathway, elucidation of immunologic events in conjunction with
administration of chemotherapy for colon cancer and definition of the mechanisms and potential therapeutic
and cancer preventive effects of resveratrol, a naturally occuring compound found in the skin of grapes.
Patients with inflammatory bowel disease, having or at high risk for colon cancer, are also studied. An
additional clinical trial with laboratory correlative studies, originally designed and written by a mentee
hematology-oncology fellow of Dr. Holcombe's involves the treatment of patients with gastric cancer.
Mentoring activity over the past 5 years and mentoring plans for the next 5 years are described. The
accomplishments of mentees are outlined as are their current activities, espeicially as related to ongoing
participation in patient-oriented research. Ongoing mentoring plans include formal coursework,
basic/translational research experiences, instruction in the development and implementation of clinical
research trials, and hands-on experiences in clinical research. The original goals and objectives of the
current award are reviewed and the extent to which these have been achieved is delineated. Documentation
of institutional support and justification of the need for continued support through the K24 mechanism is
provided.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neoadjuvant photodynamic immunomodulation for colon cancer
-
批准号:8005456
-
项目类别:
-
资助金额:$29.82万
-
财政年份:2010
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Neoadjuvant photodynamic immunomodulation for colon cancer
-
批准号:8119595
-
项目类别:
-
资助金额:$30.21万
-
财政年份:2010
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
PHASE I BIOMARKER STUDY OF DIETARY GRAPE-DERIVED LOW DOSE RESVERATROL FOR COLON
-
批准号:8166926
-
项目类别:
-
资助金额:$0.02万
-
财政年份:2009
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
PHASE I BIOMARKER STUDY OF DIETARY GRAPE-DERIVED LOW DOSE RESVERATROL FOR COLON
-
批准号:7951074
-
项目类别:
-
资助金额:$6.51万
-
财政年份:2008
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
A Phase 1 Study of CCI-779 in Combination with Imatnib *
-
批准号:7087072
-
项目类别:
-
资助金额:$24.88万
-
财政年份:2005
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Wnt Signaling in IBD-Related Colon Cancer
-
批准号:6850894
-
项目类别:
-
资助金额:$15.19万
-
财政年份:2004
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Wnt Signaling in IBD-Related Colon Cancer
-
批准号:6703346
-
项目类别:
-
资助金额:$15.15万
-
财政年份:2004
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient oriented Research--Colon CA & Cancer Immunology
-
批准号:6327470
-
项目类别:
-
资助金额:$12.79万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient oriented Research--Colon CA & Cancer Immunology
-
批准号:6874525
-
项目类别:
-
资助金额:$12.7万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient-oriented Research: Colon CA & Cancer Immunology
-
批准号:7586771
-
项目类别:
-
资助金额:$14.96万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient-oriented Research: Colon CA & Cancer Immunology
-
批准号:7097832
-
项目类别:
-
资助金额:$14.58万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient oriented Research--Colon CA & Cancer Immunology
-
批准号:6633466
-
项目类别:
-
资助金额:$12.7万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient-oriented Research: Colon CA & Cancer Immunology
-
批准号:8182171
-
项目类别:
-
资助金额:$9.12万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient-oriented Research: Colon CA & Cancer Immunology
-
批准号:7251986
-
项目类别:
-
资助金额:$14.86万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient-oriented Research: Colon CA & Cancer Immunology
-
批准号:7788097
-
项目类别:
-
资助金额:$5.84万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient oriented Research--Colon CA & Cancer Immunology
-
批准号:6514090
-
项目类别:
-
资助金额:$12.69万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
Patient oriented Research--Colon CA & Cancer Immunology
-
批准号:6726005
-
项目类别:
-
资助金额:$12.7万
-
财政年份:2001
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
University of Hawaii Cancer Center CCSG
-
批准号:9268835
-
项目类别:
-
资助金额:$11.55万
-
财政年份:1997
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
University of Hawaii Cancer Center CCSG
-
批准号:9526161
-
项目类别:
-
资助金额:$215.6万
-
财政年份:1997
-
负责人:RANDALL F HOLCOMBE
-
依托单位:
University of Hawaii Cancer Center CCSG
-
批准号:10063281
-
项目类别:
-
资助金额:$11.5万
-
财政年份:1997
-
负责人:RANDALL F HOLCOMBE
-
依托单位: